US20070192903A1 - Modified Gene Silencing - Google Patents

Modified Gene Silencing Download PDF

Info

Publication number
US20070192903A1
US20070192903A1 US11/674,207 US67420707A US2007192903A1 US 20070192903 A1 US20070192903 A1 US 20070192903A1 US 67420707 A US67420707 A US 67420707A US 2007192903 A1 US2007192903 A1 US 2007192903A1
Authority
US
United States
Prior art keywords
target gene
dna
modified
suppression element
silencing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US11/674,207
Other languages
English (en)
Inventor
Gregory R. Heck
JoAnne J. Fillatti
Jean C. Goley
Tichafa R.I. Munyikwa
Toni Voelker
Ty T. Vaughn
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to US11/674,207 priority Critical patent/US20070192903A1/en
Publication of US20070192903A1 publication Critical patent/US20070192903A1/en
Priority to US12/749,553 priority patent/US20100240128A1/en
Priority to US14/322,393 priority patent/US9765351B2/en
Priority to US15/702,384 priority patent/US20180002712A1/en
Priority to US16/701,782 priority patent/US11708577B2/en
Abandoned legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8216—Methods for controlling, regulating or enhancing expression of transgenes in plant cells
    • C12N15/8218—Antisense, co-suppression, viral induced gene silencing [VIGS], post-transcriptional induced gene silencing [PTGS]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8243—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine
    • C12N15/8247—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits involving biosynthetic or metabolic pathways, i.e. metabolic engineering, e.g. nicotine, caffeine involving modified lipid metabolism, e.g. seed oil composition

Definitions

  • Methods to control gene expression by silencing or suppressing a target gene include use of antisense, co-suppression, and RNA interference.
  • Anti-sense gene suppression in plants is described by Shewmaker et al in U.S. Pat. Nos. 5,107,065, 5453,566, and 5,759,829.
  • Gene suppression in bacteria using DNA which is complementary to mRNA encoding the gene to be suppressed is disclosed by Inouye et al. in U.S. Pat. Nos. 5,190,931, 5,208,149, and 5,272,065.
  • RNA interference or double-stranded RNA-mediated gene suppression has been described by, e. g., Redenbaugh et al.
  • total or maximal silencing or suppression is desired, for example, where a suppression element is designed to suppress a pathogen target gene in order to achieve maximal protection of the host of that pathogen.
  • complete suppression of a gene is not always preferred, for example, where complete suppression decreases viability or robustness of the organism in which the gene is silenced.
  • a desired phenotype e. g., a particular level of a metabolite or a particular combination of traits
  • This invention discloses methods of controlling gene expression or gene suppression in eukaryotic cells.
  • One aspect of the invention provides a method of modifying the degree of silencing of a target gene, including transcribing in a eukaryotic cell a modified suppression element, thereby obtaining a modified degree of silencing of the target gene, relative to a reference degree of silencing obtained through the transcription in the eukaryotic cell of a reference suppression element that corresponds to the target gene.
  • a second aspect of the invention provides a method of providing a eukaryotic cell having a desired phenotype resulting from transcription in the eukaryotic cell of a modified suppression element, including (a) providing a range of modified suppression elements, wherein each modified suppression element includes a fragment of a reference suppression element; (b) separately introducing each of the range of modified suppression elements into a eukaryotic cell, thereby producing a plurality of transgenic eukaryotic cells; (c) transcribing in each of the transgenic eukaryotic cell the modified suppression element therein introduced, and observing the resulting phenotype resulting from the transcribing; and (d) selecting from the plurality of transgenic eukaryotic cells at least one eukaryotic cell having the desired phenotype.
  • the invention further provides transgenic eukaryotic cells, and organisms containing such cells, having a phenotype resulting from suppression of a target gene by transcription in the eukaryotic cell of a modified suppression element.
  • transgenic plant cells, plants, and seeds containing modified suppression elements of the invention and useful derivatives of such transgenic plant cells, plants, or seeds, such as food or feed products.
  • Other specific embodiments of the invention are disclosed in the following detailed description.
  • FIG. 1 schematically depicts a method for mapping silencing efficacy of a suppression element, useful in designing or selecting a modified suppression element, as described in Example 1.
  • FIG. 2 depicts results of the experiments described in Example 2 as a plot of 18:1 fatty acid levels as a function of size of the suppression element.
  • FIG. 3 depicts results of the experiments described in Example 2, as a plot of 18:1 fatty acid levels as a function of size of the suppression element.
  • this invention provides a method of modifying the degree of silencing of a target gene, including transcribing in a eukaryotic cell a modified suppression element, thereby obtaining a modified degree of silencing of the target gene, relative to a reference degree of silencing obtained through the transcription in the eukaryotic cell of a reference suppression element that corresponds to the target gene.
  • the eukaryotic cell in which the suppression elements are to be transcribed can include any eukaryotic cell or cells.
  • the eukaryotic cell is selected from an animal cell and a plant cell.
  • the eukaryotic cell can be a discrete cell (e. g., a plant, yeast, fungal, insect, or mammalian cell grown under cell culture conditions), a cell in undifferentiated tissue (e. g., a callus of undifferentiated plant cells), a cell in differentiated tissue, or a cell in an intact multicellular organism (such as a plant or an animal of any age or growth or reproductive stage).
  • the target gene to be silenced can include any gene, and can include multiple genes.
  • the target gene can include a gene endogenous to the eukaryotic cell in which the suppression element is transcribed, such as a gene or genes native to the eukaryotic cell, or a transgene in a transgenic eukaryotic cell.
  • the target gene can include a gene exogenous to the eukaryotic cell in which the suppression element is transcribed, for example, a gene native to a pest or pathogen or to a symbiont (e. g., a endobiont or an endocytobiont) of the eukaryotic cell.
  • the target gene can include a single gene or part of a single gene that is targetted for suppression, or can include, e. g., multiple consecutive segments of a target gene, multiple non-consecutive segments of a target gene, multiple alleles of a target gene, or multiple target genes from one or more species.
  • the target gene includes one contiguous nucleotide sequence.
  • the target gene includes non-contiguous nucleotide sequences, e. g., non-contiguous segments of a single mRNA transcript or non-contiguous segments of a native DNA nucleotide sequence (which can include coding DNA or non-coding DNA or a combination of both).
  • the target gene can be include nucleotides in translatable (coding) sequence, or nucleotides in non-coding sequence (such as non-coding regulatory sequence), or nucleotides in both coding and non-coding sequence.
  • the target gene can include at least one eukaryotic target gene, at least one non-eukaryotic target gene, or both.
  • a target gene can include any sequence from any species (including, but not limited to, non-eukaryotes such as bacteria and viruses; fungi; plants, including monocots and dicots, such as crop plants, ornamental plants, and non-domesticated or wild plants; prokaryotic or eukaryotic symbionts including intercellular symbionts (endobionts), intracellular symbionts (endocytobionts), and external symbionts (ectosymbionts); and invertebrates (e. g., arthropods, annelids, nematodes, and molluscs); and vertebrates (e.g., amphibians, fish, birds, domestic or wild mammals, and even humans).
  • non-eukaryotes such as bacteria and viruses
  • fungi plants, including monocots and dicots, such as crop plants, ornamental plants, and non-domesticated or wild plants
  • Non-limiting examples of a target gene include non-translatable (non-coding) DNA, such as, but not limited to, 5′ untranslated regions, promoters, enhancers, or other non-coding transcriptional regions, 3′ untranslated regions, terminators, and introns.
  • Target genes can also include genes encoding microRNAs, small interfering RNAs, RNA components of ribosomes or ribozymes, small nucleolar RNAs, and other non-coding RNAs (see, for example, non-coding RNA sequences described by Griffiths-Jones et al.
  • RNAs which lack long open reading frames and function as riboregulators as described by Erdmann et al (2001) Nucleic Acids Res., 29:189-193).
  • a target gene includes a microRNA recognition site (i.e., the site on an RNA strand to which a mature miRNA binds and induces cleavage).
  • a target gene includes a microRNA precursor sequence, that is, the primary transcript encoding a microRNA, or the RNA intermediates processed from this primary transcript (e.
  • Target microRNA precursor DNA can be native to the transgenic plant of the invention, or can be native to a pest or pathogen of the transgenic plant.
  • Target DNA can also include translatable (coding) sequence for genes encoding transcription factors and genes encoding enzymes involved in the biosynthesis or catabolism of molecules (such as, but not limited to, amino acids, fatty acids and other lipids, sugars and other carbohydrates, biological polymers, and secondary metabolites including alkaloids, terpenoids, polyketides, non-ribosomal peptides, and secondary metabolites of mixed biosynthetic origin).
  • a target gene can be a native gene targetted for suppression, with or without concurrent expression (or suppression) of an exogenous transgene, e.g., by including a gene expression (or suppression) element in the same or in a separate recombinant DNA construct.
  • a native gene can be replaced with an exogenous transgene homologue.
  • the suppression element is transcribed in a transgenic plant, and suppresses a target gene which is exogenous to the host plant but endogenous to a plant pest or pathogen (e. g., viruses, bacteria, fungi, and invertebrates such as insects, nematodes, and molluscs).
  • a plant pest or pathogen e. g., viruses, bacteria, fungi, and invertebrates such as insects, nematodes, and molluscs.
  • the target gene is selected to provide resistance to a plant pest or pathogen, for example, resistance to a nematode such as soybean cyst nematode or root knot nematode or to a pest insect such as corn rootworm.
  • target genes also include endogenous genes of plant pests and pathogens.
  • Pest invertebrates include, but are not limited to, pest nematodes (e.
  • cyst nematodes Heterodera spp. especially soybean cyst nematode Heterodera glycines, root knot nematodes Meloidogyne spp., lance nematodes Hoplolaimus spp., stunt nematodes Tylenchorhynchus spp., spiral nematodes Helicotylenchus spp., lesion nematodes Pratylenchus spp., ring nematodes Criconema spp., and foliar nematodes Aphelenchus spp. or Aphelenchoides spp.), pest molluscs (slugs and snails), and pest insects (e.
  • cyst nematodes Heterodera spp. especially soybean cyst nematode Heterodera glycines, root knot nematodes Meloidogyne spp., lance nematodes Hoplolaimus
  • Plant pathogens include fungi (e.g., corn rootworms, Lygus spp., aphids, corn borers, cutworms, armyworms, leafhoppers, Japanese beetles, grasshoppers, and other pest coleopterans, dipterans, and lepidopterans).
  • Plant pathogens include fungi (e.
  • fungi that cause powdery mildew, rust, leaf spot and blight, damping-off, root rot, crown rot, cotton boll rot, stem canker, twig canker, vascular wilt, smut, or mold, including, but not limited to, Fusarium spp., Phakospora spp., Rhizoctonia spp., Aspergillus spp., Gibberella spp., Pyricularia spp., Alternaria spp., and Phytophthora spp.), bacteria (e. g., the bacteria that cause leaf spotting, fireblight, crown gall, and bacterial wilt), mollicutes (e.
  • the mycoplasmas that cause yellows disease and spiroplasmas such as Spiroplasma kunkelii, which causes corn stunt
  • viruses e. g., the viruses that cause mosaics, vein banding, flecking, spotting, or abnormal growth.
  • Spiroplasma kunkelii which causes corn stunt
  • viruses e. g., the viruses that cause mosaics, vein banding, flecking, spotting, or abnormal growth.
  • viruses e. g., the viruses that cause mosaics, vein banding, flecking, spotting, or abnormal growth.
  • Non-limiting examples of fungal plant pathogens of particular interest include Phakospora pachirhizi (Asian soy rust), Puccinia sorghi (corn common rust), Puccinia polysora (corn Southern rust), Fusarium oxysporum and other Fusarium spp., Alternaria spp., Penicillium spp., Pythium aphanidermatum and other Pythium spp., Rhizoctonia solani, Exserohilum turcicum (Northern corn leaf blight), Bipolaris maydis (Southern corn leaf blight), Ustilago maydis (corn smut), Fusarium graminearum ( Gibberella zeae ), Fusarium verticilliodes ( Gibberella moniliformis ), F.
  • Phakospora pachirhizi Asian soy rust
  • Puccinia sorghi corn common rust
  • Puccinia polysora
  • proliferatum G. fujikuroi var. intermedia
  • F. subglutinans G. subglutinans
  • Diplodia maydis, Sporisorium holci - sorghi, Colletotrichum graminicola, Setosphaeria turcica, Aureobasidium zeae, Phytophthora infestans, Phytophthora sojae, Sclerotinia sclerotiorum, and the numerous fungal species provided in Tables 4 and 5 of U.S. Pat. No. 6,194,636, incorporated by reference.
  • Non-limiting examples of bacterial pathogens include Pseudomonas avenae, Pseudomonas andropogonis, Erwinia stewartil, Pseudomonas syringae pv. syringae, and the numerous bacterial species listed in Table 3 of U.S. Pat. No. 6,194,636, incorporated by reference.
  • Non-limiting examples of viral plant pathogens of particular interest include maize dwarf mosaic virus (MDMV), sugarcane mosaic virus (SCMV, formerly MDMV strain B), wheat streak mosaic virus (WSMV), maize chlorotic dwarf virus (MCDV), barley yellow dwarf virus (BYDV), banana bunchy top virus (BBTV), and the numerous viruses listed in Table 2 of U.S. Pat. No. 6,194,636, incorporated by reference.
  • MDMV maize dwarf mosaic virus
  • SCMV sugarcane mosaic virus
  • WSMV wheat streak mosaic virus
  • MCDV maize chlorotic dwarf virus
  • BYDV barley yellow dwarf virus
  • BBTV banana bunchy top virus
  • Non-limiting examples of invertebrate pests include pests capable of infesting the root systems of crop plants, e. g., northern corn rootworm ( Diabrotica barberi ), southern corn rootworm ( Diabrotica undecimpunctata ), Western corn rootworm ( Diabrotica virgifera ), corn root aphid ( Anuraphis maidiradicis ), black cutworm ( Agrotis ipsilon ), glassy cutworm ( Crymodes devastator ), dingy cutworm ( Feltia Jerusalem prisens ), claybacked cutworm ( Agrotis gladiaria ), wireworm ( Melanotus spp., Aeolus mellillus ), wheat wireworm ( Aeolus mancus ), sand wireworm ( Horistonotus uhlerii ), maize billbug ( Sphenophorus maidis ), timothy billbug ( Sphenophorus zeae ), bluegrass billbug ( Sphenophorus parvulus
  • Target genes from pests can include invertebrate genes for major sperm protein, alpha tubulin, beta tubulin, vacuolar ATPase, glyceraldehyde-3-phosphate dehydrogenase, RNA polymerase II, chitin synthase, cytochromes, miRNAs, miRNA precursor molecules, miRNA promoters, as well as other genes such as those disclosed in Table II of United States Patent Application Publication 2004/0098761 A1, incorporated by reference.
  • Target genes from pathogens can include genes for viral translation initiation factors, viral replicases, miRNAs, miRNA precursor molecules, fungal tubulin, fungal vacuolar ATPase, fungal chitin synthase, enzymes involved in fungal cell wall biosynthesis, cutinases, melanin biosynthetic enzymes, polygalacturonases, pectinases, pectin lyases, cellulases, proteases, and other genes involved in invasion and replication of the pathogen in the infected plant.
  • a target gene need not be endogenous to the plant in which the suppression element is transcribed.
  • a suppression element can be transcribed in a plant and used to suppress a gene of a pathogen or pest that may infest the plant.
  • suitable target genes also include amino acid catabolic genes (such as, but not limited to, the maize LKR/SDH gene encoding lysine-ketoglutarate reductase (LKR) and saccharopine dehydrogenase (SDH), and its homologues), maize zein genes, genes involved in fatty acid synthesis (e. g., plant microsomal fatty acid desaturases and plant acyl-ACP thioesterases, such as, but not limited to, those disclosed in U.S. Pat. Nos.
  • amino acid catabolic genes such as, but not limited to, the maize LKR/SDH gene encoding lysine-ketoglutarate reductase (LKR) and saccharopine dehydrogenase (SDH), and its homologues
  • maize zein genes genes involved in fatty acid synthesis (e. g., plant microsomal fatty acid desaturases and plant acyl-ACP thioesterase
  • genes involved in multi-step biosynthesis pathways where it may be of interest to regulate the level of one or more intermediates, such as genes encoding enzymes for polyhydroxyalkanoate biosynthesis (see, for example, U.S. Pat. No. 5,750,848); and genes encoding cell-cycle control proteins, such as proteins with cyclin-dependent kinase (CDK) inhibitor-like activity (see, for example, genes disclosed in International Patent Application Publication Number WO 05007829A2).
  • Target genes include genes encoding undesirable proteins (e. g., allergens or toxins) or the enzymes for the biosynthesis of undesirable compounds (e. g., undesirable flavor or odor components).
  • one embodiment of the invention is a transgenic plant or tissue of such a plant that is improved by the suppression of allergenic proteins or toxins, e. g., a peanut, soybean, or wheat kernel with decreased allergenicity.
  • Target genes include genes involved in fruit ripening, such as polygalacturonase.
  • Target genes include genes where expression is preferably limited to a particular cell or tissue or developmental stage, or where expression is preferably transient, that is to say, where constitutive or general suppression, or suppression that spreads through many tissues, is not necessarily desired.
  • suitable target genes include genes encoding proteins that, when expressed in transgenic plants, make the transgenic plants resistant to pests or pathogens (see, for example, genes for cholesterol oxidase as disclosed in U.S. Pat. No. 5,763,245); genes where expression is pest- or pathogen-induced; and genes which can induce or restore fertility (see, for example, the barstar/barnase genes described in U.S. Pat. No. 6,759,575).
  • the suppression elements of use in the method can be any suppression element (or combination of elements) that, when transcribed in the eukaryotic cell, results in silencing of the target gene.
  • the suppression element can be transcribable DNA of any suitable length, and will generally include at least about 19 to about 27 nucleotides (for example 19, 20, 21, 22, 23, or 24 nucleotides) for every target gene.
  • the suppression element includes more than 23 nucleotides (for example, more than about 30, about 50, about 100, about 200, about 300, about 500, about 1000, about 1500, about 2000, about 3000, about 4000, or about 5000 nucleotides) for every target gene intended to be suppressed.
  • the suppression element includes “sense” sequence (i.
  • the modified and reference suppression elements transcribe to at least partially double-stranded RNA. Suitable gene suppression elements are described in detail in U.S. Patent Application Publication 2006/0200878, incorporated by reference, and can be of any one or more types, including:
  • suppression elements can be designed to suppress more than one target gene, including, for example, more than one allele of a target gene, multiple target genes (or multiple segments of at least one target gene) from a single species, or target genes from different species.
  • these multiple copies can be arranged serially in tandem repeats. In some embodiments, these multiple copies can be arranged serially end-to-end, that is, in directly connected tandem repeats. In some embodiments, these multiple copies can be arranged serially in interrupted tandem repeats, where one or more spacer DNA segments can be located adjacent to one or more of the multiple copies. Tandem repeats, whether directly connected or interrupted or a combination of both, can include multiple copies of a single anti-sense or multiple copies of a single sense DNA sequence in a serial arrangement or can include multiple copies of more than one anti-sense DNA sequence or of more than one sense DNA sequence in a serial arrangement. Where the suppression element includes multiple copies, the degree of complementarity can be, but need not be, identical for all of the multiple copies.
  • the reference suppression element and the modified suppression element are of similar types, e. g., both the reference suppression element and the modified suppression element include DNA that transcribes to RNA for suppressing the target gene by forming double-stranded RNA and includes at least one anti-sense DNA segment that is anti-sense to at least one segment of the target gene and at least one sense DNA segment that is at least one segment of the target gene.
  • the modified suppression element and reference suppression element may be of different types, e. g., the reference suppression element includes an antisense DNA segment that is anti-sense to one or more segments of the target gene, whereas the modified suppression element includes multiple copies of the same or modified anti-sense DNA segment.
  • RNA transcribed from either the at least one anti-sense or at least one sense DNA can become double-stranded by the action of an RNA-dependent RNA polymerase (see, for example, U.S. Pat. No. 5,283,184).
  • the double-stranded RNA can be in the form of a single dsRNA “stem” (region of base-pairing between sense and anti-sense strands), or can have multiple dsRNA “stems”.
  • Such multiple dsRNA “stems” can further be arranged in series or clusters to form tandem inverted repeats, or structures resembling “hammerhead” or “cloverleaf′ shapes.
  • Any of these suppression elements can further include spacer DNA segments found within a dsRNA “stem” (for example, as a spacer between multiple anti-sense or sense DNA segments or as a spacer between a base-pairing anti-sense DNA segment and a sense DNA segment) or outside of a double-stranded RNA “stem” (for example, as a loop region separating a pair of inverted repeats).
  • the longer segment can act as a spacer.
  • the suppression element can include spacer DNA, which can be virtually any DNA (such as, but not limited to, translatable DNA sequence encoding a gene, translatable DNA sequence encoding a marker or reporter gene; transcribable DNA derived from an intron, which upon transcription can be excised from the resulting transcribed RNA; transcribable DNA sequence encoding RNA that forms a structure such as a loop or stem or an aptamer capable of binding to a specific ligand; spliceable DNA such as introns and self-splicing ribozymes; transcribable DNA encoding a sequence for detection by nucleic acid hybridization, amplification, or sequencing; and a combination of these).
  • spacer DNA can be virtually any DNA (such as, but not limited to, translatable DNA sequence encoding a gene, translatable DNA sequence encoding a marker or reporter gene; transcribable DNA derived from an intron, which upon transcription can be excised from the resulting transcribed RNA; trans
  • Spacer DNA can be found, for example, between parts of a suppression element, or between different suppression elements.
  • spacer DNA is itself sense or anti-sense sequence of the target gene.
  • the RNA transcribed from the spacer DNA e. g., a large loop of antisense sequence of the target gene or an aptamer
  • the suppression element can include DNA that includes nucleotides derived from a miRNA (microRNA), that is, a DNA sequence that corresponds to a miRNA native to a virus or a eukaryote (including plants and animals, especially invertebrates), or a DNA sequence derived from such a native miRNA but modified to include nucleotide sequences that do not correspond to the native miRNA.
  • miRNA miRNA
  • a particularly preferred embodiment includes a suppression element containing DNA that includes nucleotides derived from a viral or plant miRNA.
  • a further embodiment includes a suppression element with DNA sequence that corresponds to a miRNA that is native to a fungus.
  • the nucleotides derived from a miRNA can include DNA that includes nucleotides corresponding to the loop region of a native miRNA and nucleotides that are selected from a target gene sequence.
  • the nucleotides derived from a miRNA can include DNA derived from a miRNA precursor sequence, such as a native pri-miRNA or pre-miRNA sequence, or nucleotides corresponding to the regions of a native miRNA and nucleotides that are selected from a target gene sequence number such that the overall structure (e.
  • the suppression element can include DNA that includes nucleotides derived from a miRNA and capable of inducing or guiding in-phase cleavage of an endogenous transcript into trans-acting siRNAs, as described by Allen et al. (2005) Cell, 121:207-221.
  • the DNA that includes nucleotides derived from a miRNA can include sequence naturally occurring in a miRNA or a miRNA precursor molecule, synthetic sequence, or both.
  • the suppression element is included in a recombinant DNA construct that is useful in producing a transgenic eukaryotic cell.
  • a construct includes a promoter that is able to initiate transcription in the eukaryotic cell, and that is operably linked, directly or with intervening sequences, to the suppression element.
  • the construct can optionally include a terminator element.
  • the promoter element is functional in an animal.
  • the promoter element is functional in a plant.
  • the promoter element can include a promoter selected from the group consisting of a constitutive promoter, a spatially specific promoter, a temporally specific promoter, a developmentally specific promoter, and an inducible promoter.
  • spatially specific promoters can include organelle-, cell-, tissue-, or organ-specific promoters functional in a plant (e.
  • spatially specific promoters include promoters that have enhanced activity in a particular animal cell or tissue (e. g., enhanced or specific promoter activity in nervous tissue, liver, muscle, eye, blood, marrow, breast, prostate, gonads, or other tissues).
  • Temporally specific promoters can include promoters that tend to promote expression during certain developmental stages in an animal or plant's growth or reproductive cycle, or during different times of day or night, or at different seasons in a year.
  • Inducible promoters include promoters induced by chemicals (e. g., exogenous or synthetic chemicals as well as endogenous pheromones and other signaling molecules) or by environmental conditions such as, but not limited to, biotic or abiotic stress (e. g., water deficit or drought, heat, cold, high or low nutrient or salt levels, high or low light levels, or pest or pathogen infection).
  • An expression-specific promoter can also include promoters that are generally constitutively expressed but at differing degrees or “strengths” of expression, including promoters commonly regarded as “strong promoters” or as “weak promoters”.
  • the promoter element can include nucleic acid sequences that are not naturally occurring promoters or promoter elements or homologues thereof but that can regulate expression of a gene. Examples of such “gene independent” regulatory sequences include naturally occurring or artificially designed RNA sequences that include a ligand-binding region or aptamer and a regulatory region (which can be cis-acting). See, for example, the discussion of RNA regulatory elements (“riboregulators”) given by Isaacs et al. (2004) Nat.
  • a recombinant DNA construct containing the suppression element includes both a promoter element and a functional terminator element.
  • the terminator element includes a functional polyadenylation signal and polyadenylation site, allowing RNA transcribed from the recombinant DNA construct to be polyadenylated and processed for transport into the cytoplasm.
  • a functional terminator element is absent.
  • at least one of a functional polyadenylation signal and a functional polyadenylation site is absent.
  • a 3′ untranslated region is absent. In these cases, the recombinant DNA construct is transcribed as unpolyadenylated RNA and is preferably not transported into the cytoplasm.
  • the suppression element is embedded within an intron, which is preferably an intron flanked on one or on both sides by non-protein-coding DNA.
  • an intron is preferably an intron flanked on one or on both sides by non-protein-coding DNA.
  • One non-limiting embodiment is a recombinant DNA construct that consists entirely of non-coding DNA and that includes the suppression element (or elements) embedded within an intron.
  • Introns suitable for use in constructs of the invention can be viral introns (e. g., Yamada et al (1994) Nucleic Acids Res., 22:2532-2537), eukaryotic introns (including animal, fungal, and plant introns), archeal or bacterial introns (e. g., Belfort et al. (1995) J.
  • Examples of especially preferred plant introns include a rice actin 1 intron (I-Os-Act1) (Wang et al (1992) Mol. Cell Biol., 12:3399-3406; McElroy et al. (1990) Plant Cell, 2:163-171), a maize heat shock protein intron (I-Zm-hsp70) (U.S. Pat. Nos. 5,593,874 and 5,859,347), and a maize alcohol dehydrogenase intron (I-Zm-adh1) (Callis et al. (1987) Genes Dev., 1:1183-1200).
  • I-Os-Act1 rice actin 1 intron
  • I-Zm-hsp70 maize heat shock protein intron
  • I-Zm-adh1 maize alcohol dehydrogenase intron
  • introns suitable for use in the invention include the tobacco mosaic virus 5′ leader sequence or “omega” leader (Gallie and Walbot (1992) Nucleic Acids Res., 20:4631-4638), the Shrunken-1 (Sh-1) intron (Vasil et al. (1989) Plant Physiol., 91:1575-1579), the maize sucrose synthase intron (Clancy and Hannah (2002) Plant Physiol., 130:918-929), the heat shock protein 18 (hsp18) intron (Silva et al. (1987) J.
  • the suppression element is included in a recombinant DNA construct that also includes at least one expression element (e. g., to express a gene of interest, a reporter gene, or a marker gene) or additional suppression elements.
  • at least one expression element e. g., to express a gene of interest, a reporter gene, or a marker gene
  • the reference suppression element is any suppression element (see “Suppression Elements” beginning at paragraph 0025 above) used to establish a reference degree of silencing (see “Degrees of Silencing” beginning at paragraph 0050 below).
  • the modified suppression element is any suppression element that is different but derived from the reference suppression element.
  • modification of the reference suppression element to obtain one or more modified suppression elements can involve changing the reference suppression element's size (e. g., by fragmentation or truncation), changing the reference suppression element's nucleotide sequence (e.
  • nucleotides g., by substitution or deletion of nucleotides), changing the arrangement of the order and/or number of reference suppression fragments, changing the reference suppression element's orientation (sense or anti-sense) or position in a recombinant DNA construct, or inclusion or deletion of stabilizing or destabilizing elements.
  • the modified suppression element includes at least one fragment of the reference suppression element. In some embodiments, the modified suppression element includes multiple fragments of the reference suppression element, which can be multiple different fragments of the reference suppression element or multiple copies of one or more fragments of the reference suppression element. Where the modified suppression elements includes multiple different fragments of the reference suppression element, the multiple different fragments can be in the same order as, or in an order different from, that in which they are arranged in the reference suppression element. In another embodiment, the modified suppression element is obtained by modification of the suppression element to target one or more fragments (e. g., truncations) of the target gene
  • At least one fragment of the reference suppression element may be provided in a cell by any suitable means.
  • the at least one fragment is obtained by truncation of the reference suppression element.
  • Such truncation includes deletion of one or more nucleotides from the 5′ end, from the 3′ end, or from both the 5′ and 3′ ends of the reference suppression element.
  • the at least one fragment is provided by deletion of one or more internal (non-terminal) nucleotides from the reference suppression element. Deletion can be of a single sequence of contiguous nucleotides from the reference suppression element, or of multiple such sequences.
  • the at least one fragment is at least 19 contiguous nucleotides in length, but the fragment can be any length necessary to obtain the desired degree of silencing, e. g., at least 21, at least 22, at least 23, or at least 24 nucleotides.
  • the fragment can include more than about 25, about 50, about 75, about 100, about 150, about 200, about 300, or about 500 nucleotides or greater.
  • the at least one fragment can include between about 1% to about 98%, e.
  • the at least one fragment can be less than 1 % of the length of the reference suppression element.
  • the modified suppression element is selected by mapping the silencing efficacy for the target gene.
  • Mapping can involve predictive methods or empirical determination of silencing efficacy. Predictive methods include, e. g., use of the criteria for predicting the efficiency at which a given siRNA would function as identified by Reynolds et al. (2004) Nature Biotechnol., 22:326-330, and further described in United States Patent Application Publication 2005/0255487, which is incorporated by reference,.
  • mapping consists primarily or entirely of empirical determination of silencing efficacy.
  • Empirical determination of silencing efficacy can include determining actual gene silencing (e.
  • Proxy measurements can include, for example, measuring a trait or phenotype that results from expression of the target gene (e. g., measuring the level of a metabolic product, a measurable phenotype of a transgenic organism such as growth rate or yield or pest resistance of a transgenic plant).
  • Mapping can be carried out at any suitable resolution (in terms of nucleotide length of a potential suppression element) of the target gene.
  • fine mapping includes determination and/or prediction of efficacy of a minimum suppression element size, e. g., at least 19 contiguous nucleotides in length, or at least 21, at least 22, at least 23, or at least 24 nucleotides in length.
  • mapping can be carried out for any length of suppression element, including suppression elements that are larger than the reference suppression element.
  • the modified selection element is further selected or adapted to avoid silencing of non-target genes, or to avoid generation of undesirable polypeptides, or both.
  • Non-target genes can include any gene not intended to be silenced or suppressed, in the eukaryotic cell in which the suppression element is transcribed or in organisms that may come into contact with the transcribed suppression element or its products.
  • the suppression element can include nucleotide sequence selected to be specific for one taxon (for example, specific to a genus, family, or even a larger taxon such as a phylum, e. g., arthropoda) but not for other taxa (for example, plants or vertebrates or mammals).
  • a suppression element includes nucleotide sequence for dsRNA-mediated gene silencing in corn rootworm that is selected to be specific to all members of the genus Diabrotica.
  • such a Diabrotica -targetted suppression element is selected so as to not contain nucleotide sequence from beneficial coleopterans (for example, predatory coccinellid beetles, commonly known as ladybugs or ladybirds) or other beneficial insect species.
  • beneficial coleopterans for example, predatory coccinellid beetles, commonly known as ladybugs or ladybirds
  • beneficial insect species for example, predatory coccinellid beetles, commonly known as ladybugs or ladybirds
  • the modified suppression element is further selected or adapted to avoid generation of undesirable polypeptides.
  • a suppression element can be screened to eliminate or minimize sequences that encode known undesirable polypeptides or close homologues of these.
  • Undesirable polypeptides include, but are not limited to, polypeptides homologous to known allergenic polypeptides and polypeptides homologous to known polypeptide toxins. Sequences encoding such undesirable potentially allergenic peptides are known in the art (e. g., Gendel (1998) Adv. Food Nutr. Res., 42:63-92) and are publicly available, for example, at the Food Allergy Research and Resource Program (FARRP) allergen database or the Biotechnology Information for Food Safety Databases.
  • FARRP Food Allergy Research and Resource Program
  • Undesirable sequences can also include, for example, those polypeptide sequences annotated as known toxins or as potential or known allergens and contained in publicly available databases such as GenBank, EMBL, SwissProt, and others, which are searchable by the Entrez system.
  • Non-limiting examples of undesirable, potentially allergenic peptide sequences include glycinin from soybean, oleosin and agglutinin from peanut, glutenins from wheat, casein, lactalbumin, and lactoglobulin from bovine milk, and tropomysosin from various shellfish.
  • Non-limiting examples of undesirable, potentially toxic peptides include tetanus toxin tetA from Clostridium tetani, diarrheal toxins from Staphylococcus aureus, and venoms such as conotoxins from Conus spp. and neurotoxins from arthropods and reptiles.
  • potential suppression element sequences were screened to eliminate those sequences encoding polypeptides with perfect homology to a known allergen or toxin over 8 contiguous amino acids, or with at least 35% identity over at least 80 amino acids; such screens can be performed on any and all possible reading frames in both directions, on potential open reading frames that begin with ATG, or on all possible reading frames, regardless of whether they start with an ATG or not.
  • screens (referred to as “EAT/Tox” screens) were routinely performed on the transcribed portions of suppression elements that are intended to produce a double stranded RNA but are not intended to be translated into a polypeptide. These screens can be performed on any and all possible reading frames in both directions, and on potential open reading frames that begin with ATG, or on all possible reading frames, regardless of whether they start with an ATG or not.
  • a “hit” or match that is, when a sequence that encodes a potential polypeptide with perfect homology to a known allergen or toxin over 8 contiguous amino acids (or at least about 35% identity over at least about 80 amino acids), is identified, the nucleotide sequences corresponding to the hit can be avoided, eliminated, or modified when selecting a suppression element.
  • Avoiding, elimination of, or modification of, an undesired sequence may be achieved by any of a number of methods known to those skilled in the art.
  • the result may be novel sequences that are believed to not exist naturally.
  • avoiding certain sequences can be accomplished by joining together “clean” sequences into novel chimeric suppression element that will produce a novel transcript, most preferably a transcript that provides the desired modified level of suppression.
  • a suppression element need not always have 100% sequence identity with (or 100% complementary to) the intended target gene, but generally would preferably have substantial sequence identity (or complementarity) with the intended target gene, such as about 95%, about 90%, about 85%, or about 80% sequence identity with (or complementarity to) the intended target gene.
  • One skilled in the art would be capable of judging the importance given to screening for regions predicted to be more highly specific to the target gene or predicted to not generate undesirable polypeptides, relative to the importance given to other criteria, such as, but not limited to, the percent sequence identity with the intended target gene or the predicted or empirically determined silencing efficacy of a given suppression element. For example, it may be desirable for a given suppression element to be active across several species, and therefore one skilled in the art may determine that it is more important to include regions specific to the several species of interest, but less important to screen for regions predicted to have higher gene silencing efficiency or for regions predicted to generate undesirable polypeptides.
  • Reference Suppression Elements and Modified Suppression Elements results in the suppression of expression of the target gene at a certain level (termed the “reference degree of silencing”), relative to the level of expression of the target gene in the absence of such transcription.
  • the reference degree of silencing is not an absolute level of suppression but rather is a level of suppression selected as a benchmark for comparison with the level of suppression by alternative suppression elements.
  • the reference degree of silencing of the target gene can be any level of suppression, from about zero suppression (relative to expression in the absence of transcription of the reference suppression element) to about complete suppression, or any level in between, and the degree of silencing can be selected as described herein to achieve a desired level of modulation of expression of the targetted sequence (or target gene).
  • Use of the term “reference degree of silencing” in this context is not meant to imply a “maximum” or “optimal” degree of silencing.
  • Transcription in the eukaryotic cell of a modified suppression element preferably results in a level of suppression of expression of the target gene that differs from that obtained by transcription of the reference suppression element, wherein such level of suppression is termed the “modified degree of silencing”.
  • the modified degree of silencing is increased silencing of the target gene, relative to the reference degree of silencing. In other embodiments, the modified degree of silencing is decreased silencing of the target gene, relative to the reference degree of silencing.
  • Detecting or measuring the degree of silencing of a target gene resulting from transcription of the suppression element can be achieved by any suitable method to detect the expression (or suppression) of DNA sequence or the RNA transcript corresponding to the target gene, or of a peptide encoded by the target gene.
  • suitable methods include protein detection methods (e. g., western blots, ELISAs, and other immunochemical methods, and measurements of enzymatic activity), or nucleic acid detection methods (e. g., Southern blots, northern blots, PCR, RT-PCR, fluorescent in situ hybridization, and TaqMAN assays).
  • protein detection methods e. g., western blots, ELISAs, and other immunochemical methods, and measurements of enzymatic activity
  • nucleic acid detection methods e. g., Southern blots, northern blots, PCR, RT-PCR, fluorescent in situ hybridization, and TaqMAN assays.
  • Such methods are well known to those of ordinary
  • proxy indications include, e. g., gross or microscopic morphological traits, growth rates, yield, reproductive or recruitment rates, resistance to pests or pathogens, or resistance to biotic or abiotic stress (e. g., water deficit stress, salt stress, nutrient stress, heat or cold stress).
  • Proxy measurements of gene suppression include measurements of a phenotypic trait (e.
  • in vitro assays e. g., plant part assays such as leaf or root assays to indicate tolerance of abiotic stress.
  • the invention provides a method of providing a eukaryotic cell having a desired phenotype resulting from transcription in the eukaryotic cell of a modified suppression element, including (a) providing a range of modified suppression elements, wherein each modified suppression element includes a fragment of a reference suppression element; (b) separately introducing each of the range of modified suppression elements into a eukaryotic cell, thereby producing a plurality of transgenic eukaryotic cells; (c) transcribing in each of the transgenic eukaryotic cell the modified suppression element therein introduced, and observing the resulting phenotype resulting from the transcribing; and (d) selecting from the plurality of transgenic eukaryotic cells at least one eukaryotic cell having the desired phenotype.
  • the range of modified suppression elements includes any suitable number of modified suppression elements of one or more suppression element types as described under “Suppression Elements” (beginning at paragraph 0025 above) and “Reference Suppression Elements and Modified Suppression Elements” (beginning at paragraph 0038 above).
  • the eukaryotic cell includes a transgenic plant cell.
  • the method further includes growing a transgenic plant including the transgenic plant cell. Suitable techniques for producing a transgenic plant including the transgenic plant cell are described under “Making and Using Transgenic Plant Cells and Transgenic Plants” beginning at paragraph 0057 below.
  • the suppression is transcribed in a transgenic plant cell.
  • the transgenic plant cell can be an isolated plant cell (e. g., individual plant cells or cells grown in or on an artificial culture medium), or can be a plant cell in undifferentiated tissue (e. g., callus or any aggregation of plant cells).
  • the transgenic plant cell can be a plant cell in at least one differentiated tissue selected from the group consisting of leaf (e. g., petiole and blade), root, stem (e. g., tuber, rhizome, stolon, bulb, and corm) stalk (e. g., xylem, phloem), wood, seed, fruit (e.
  • the invention further provides a transgenic plant having in its genome any of the reference or modified suppression elements (or recombinant DNA constructs including the reference or modified suppression element) presently disclosed, including a regenerated plant prepared from the transgenic plant cells disclosed and claimed herein, or a progeny plant (which can be a hybrid progeny plant) of the regenerated plant, or seed of such a transgenic plant. Also provided is a transgenic seed having in its genome any of the reference or modified suppression elements or recombinant DNA constructs presently disclosed, and a transgenic plant grown from such transgenic seed.
  • the transgenic plant cell or plant of the invention can be any plant cell or plant. Stably transformed transgenic plants are particularly preferred.
  • the transgenic plant is a fertile transgenic plant from which seed can be harvested, and thus the invention further claims seed of such transgenic plants, wherein the seed is preferably also transgenic, that is, preferably contains the reference or modified suppression elements or recombinant DNA constructs of the invention.
  • the transformation can include any of the well-known and demonstrated methods and compositions.
  • Suitable methods for plant transformation include virtually any method by which DNA can be introduced into a cell, such as by direct delivery of DNA (e. g., by PEG-mediated transformation of protoplasts, by electroporation, by agitation with silicon carbide fibers, and by acceleration of DNA coated particles), by Agrobacterium -mediated transformation, by viral or other vectors, etc.
  • One preferred method of plant transformation is microprojectile bombardment, for example, as illustrated in U.S. Pat. No. 5,015,580 (soy), U.S. Pat. No.
  • the transgenic plant cell of the invention is obtained by transformation by means of Agrobacterium containing a binary Ti plasmid system, wherein the Agrobacterium carries a first Ti plasmid and a second, chimeric plasmid containing at least one T-DNA border of a wild-type Ti plasmid, a promoter functional in the transformed plant cell and operably linked to a gene suppression construct of the invention.
  • Agrobacterium containing a binary Ti plasmid system
  • the Agrobacterium carries a first Ti plasmid and a second, chimeric plasmid containing at least one T-DNA border of a wild-type Ti plasmid, a promoter functional in the transformed plant cell and operably linked to a gene suppression construct of the invention.
  • the smaller plasmid, containing the T-DNA border or borders can be conveniently constructed and manipulated in a suitable alternative host, such as E. coli, and then transferred into Agrobacterium.
  • Transgenic plant cells and transgenic plants can also be obtained by transformation with other vectors, such as, but not limited to, viral vectors (e. g., tobacco etch potyvirus (TEV), barley stripe mosaic virus (BSMV), and the viruses referenced in Edwardson and Christie, “The Potyvirus Group: Monograph No. 16, 1991, Agric. Exp. Station, Univ.
  • viral vectors e. g., tobacco etch potyvirus (TEV), barley stripe mosaic virus (BSMV)
  • BSMV barley stripe mosaic virus
  • plasmids e.g., bacterial infection (e. g., with Agrobacterium as described above), binary bacterial artificial chromosome constructs, direct delivery of DNA (e. g., via PEG-mediated transformation, desiccation/inhibition-mediated DNA uptake, electroporation, agitation with silicon carbide fibers, and microprojectile bombardment).
  • transformation protocol e.g., bacterial infection (e. g., with Agrobacterium as described above), binary bacterial artificial chromosome constructs, direct delivery of DNA (e. g., via PEG-mediated transformation, desiccation/inhibition-mediated DNA uptake, electroporation, agitation with silicon carbide fibers, and microprojectile bombardment).
  • Transformation methods to provide transgenic plant cells and transgenic plants containing stably integrated recombinant DNA are preferably practiced in tissue culture on media and in a controlled environment.
  • Media refers to the numerous nutrient mixtures that are used to grow cells in vitro, that is, outside of the intact living organism.
  • Recipient cell targets include, but are not limited to, meristem cells, callus, immature embryos or parts of embryos, and gametic cells such as microspores, pollen, sperm, and egg cells. It is contemplated that any cell from which a fertile plant can be regenerated can be useful as a recipient cell for practice of the invention.
  • Callus can be initiated from various tissue sources, including, but not limited to, immature embryos or parts of embryos, seedling apical meristems, microspores, and the like. Those cells which are capable of proliferating as callus can serve as recipient cells for genetic transformation.
  • Practical transformation methods and materials for making transgenic plants of this invention e. g., various media and recipient target cells, transformation of immature embryos, and subsequent regeneration of fertile transgenic plants) are disclosed, for example, in U.S. Pat. Nos. 6,194,636 and 6,232,526 and United States Application Publication 2004/0216189.
  • Marker genes are generally used to provide an efficient system for identification of those cells that are stably transformed by receiving and integrating a transgenic DNA construct into their genomes.
  • Preferred marker genes provide selective markers which confer resistance to a selective agent, such as an antibiotic or herbicide. Any of the antibiotics or herbicides to which a plant cell may be resistant can be a useful agent for selection.
  • Potentially transformed cells are exposed to the selective agent. In the population of surviving cells will be those cells where, generally, the resistance-conferring gene is integrated and expressed at sufficient levels to permit cell survival. Cells can be tested further to confirm stable integration of the recombinant DNA.
  • selective marker genes include those conferring resistance to antibiotics such as kanamycin or paromomycin (nptII), hygromycin B (aph IV) and gentamycin (aac3 and aacC4) or resistance to herbicides such as glufosinate (bar or pat) and glyphosate (EPSPS). Examples of useful selective marker genes and selection agents are illustrated in U.S. Pat. Nos. 5,550,318, 5,633,435, 5,780,708, and 6,118,047. Screenable markers or reporters, such as markers that provide an ability to visually identify transformants can also be employed.
  • Non-limiting examples of useful screenable markers include, for example, a gene expressing a protein that produces a detectable color by acting on a chromogenic substrate (e. g., beta-glucuronidase (GUS) (uidA) or luciferase (luc)) or that itself is detectable, such as green fluorescent protein (GFP) (gfp) or an immunogenic molecule.
  • a chromogenic substrate e. g., beta-glucuronidase (GUS) (uidA) or luciferase (luc)
  • GFP green fluorescent protein
  • gfp green fluorescent protein
  • the recombinant DNA constructs of the invention can be stacked with other recombinant DNA for imparting additional traits (e. g., in the case of transformed plants, traits including herbicide resistance, pest resistance, cold germination tolerance, water deficit tolerance, and the like) for example, by expressing or suppressing other genes.
  • additional traits e. g., in the case of transformed plants, traits including herbicide resistance, pest resistance, cold germination tolerance, water deficit tolerance, and the like.
  • Constructs for coordinated decrease and increase of gene expression are disclosed in United States Patent Application Publication 2004/0126845 A1.
  • transgenic plants can be prepared by crossing a first plant having the reference or modified suppression elements or recombinant DNA constructs with a second plant lacking the reference or modified suppression elements or recombinant DNA constructs.
  • recombinant DNA can be introduced into a plant line that is amenable to transformation to produce a transgenic plant, which can be crossed with a second plant line to introgress the recombinant DNA into the resulting progeny.
  • a transgenic plant with the reference or modified suppression elements or recombinant DNA constructs can be crossed with a plant line having other recombinant DNA that confers one or more additional trait(s) (such as, but not limited to, herbicide resistance, pest or disease resistance, environmental stress resistance, modified nutrient content, and yield improvement) to produce progeny plants having recombinant DNA that confers both the desired target sequence expression behavior and the additional trait(s).
  • additional trait(s) such as, but not limited to, herbicide resistance, pest or disease resistance, environmental stress resistance, modified nutrient content, and yield improvement
  • the transgenic plant donating the additional trait is a male line and the transgenic plant carrying the base traits is the female line.
  • the progeny of this cross segregate such that some of the plant will carry the DNA for both parental traits and some will carry DNA for one parental trait; such plants can be identified by markers associated with parental recombinant DNA
  • Progeny plants carrying DNA for both parental traits can be crossed back into the female parent line multiple times, e. g., usually 6 to 8 generations, to produce a progeny plant with substantially the same genotype as one original transgenic parental line but for the recombinant DNA of the other transgenic parental line.
  • transgenic plant grown from the transgenic seed of the invention.
  • This invention contemplates transgenic plants grown directly from transgenic seed containing the reference or modified suppression elements or recombinant DNA constructs as well as progeny generations of plants, including inbred or hybrid plant lines, made by crossing a transgenic plant grown directly from transgenic seed to a second plant not grown from the same transgenic seed.
  • Crossing can include, for example, the following steps:
  • the progeny are hemizygous for loci controlling the characteristic being transferred, but are like the superior parent for most or almost all other genes.
  • the last backcross generation would be selfed to give progeny which are pure breeding for the gene(s) being transferred, i. e., one or more transformation events.
  • a selected DNA construct can be moved from one line into an entirely different line without the need for further recombinant manipulation.
  • By crossing different inbred plants one can produce a large number of different hybrids with different combinations of DNA constructs. In this way, plants can be produced which have the desirable agronomic properties frequently associated with hybrids (“hybrid vigor”), as well as the desirable characteristics imparted by one or more DNA constructs.
  • Genetic markers can be used to assist in the introgression of one or more DNA constructs of the invention from one genetic background into another. Marker assisted selection offers advantages relative to conventional breeding in that it can be used to avoid errors caused by phenotypic variations. Further, genetic markers can provide data regarding the relative degree of elite germplasm in the individual progeny of a particular cross. For example, when a plant with a desired trait which otherwise has a non-agronomically desirable genetic background is crossed to an elite parent, genetic markers can be used to select progeny which not only possess the trait of interest, but also have a relatively large proportion of the desired germplasm. In this way, the number of generations required to introgress one or more traits into a particular genetic background is minimized.
  • the transgenic plant contains recombinant DNA further including a gene expression (or suppression) element for expressing at least one gene of interest, and regulation of expression of a target gene is preferably effected with concurrent expression (or suppression) of the at least one gene of interest in the transgenic plant.
  • transgenic plant cells or transgenic plants can be obtained by use of any appropriate transient or stable, integrative or non-integrative transformation method known in the art or presently disclosed.
  • the reference or modified suppression elements or recombinant DNA constructs can be transcribed in any plant cell or tissue or in a whole plant of any developmental stage.
  • Transgenic plants can be derived from any monocot or dicot plant, such as, but not limited to, plants of commercial or agricultural interest, such as crop plants (especially crop plants used for human food or animal feed), wood- or pulp-producing trees, vegetable plants, fruit plants, and ornamental plants.
  • Non-limiting examples of plants include grain crop plants (such as wheat, oat, barley, maize, rye, triticale, rice, millet, sorghum, quinoa, amaranth, and buckwheat); forage crop plants (such as forage grasses and forage dicots including alfalfa, vetch, clover, and the like); oilseed crop plants (such as cotton, safflower, sunflower, soybean, canola, rapeseed, flax, peanuts, and oil palm); tree nuts (such as walnut, cashew, hazelnut, pecan, almond, and the like); sugarcane, coconut, date palm, olive, sugarbeet, tea, and coffee; wood- or pulp-producing trees; vegetable crop plants such as legumes (for example, beans, peas, lentils, alfalfa, peanut), lettuce, asparagus, artichoke, celery, carrot, radish, the brassicas (for example, cabbages, kales, mustards, and other leaf
  • Preferred dicot plants include, but are not limited to, canola, cotton, potato, quinoa, amaranth, buckwheat, safflower, soybean, sugarbeet, and sunflower, more preferably soybean, canola, and cotton.
  • Preferred monocots include, but are not limited to, wheat, oat, barley, maize, rye, triticale, rice, ornamental and forage grasses, sorghum, millet, and sugarcane, more preferably maize, wheat, and rice.
  • transgenic plants of the invention can be used for virtually any purpose deemed of value to the grower or to the consumer.
  • maize is used extensively in the food and feed industries, as well as in industrial applications. Further discussion of the uses of maize can be found, for example, in U.S. Pat. Nos.
  • the suppression element is transcribed in a transgenic plant cell contained in a transgenic plant or plant tissue, resulting in at least one altered trait, relative to a plant or plant tissue lacking the suppression element, selected from the group of traits consisting of:
  • the transgenic plant cell, plant tissue, or plant is characterized by: improved tolerance of abiotic stress (e. g., tolerance of water deficit or drought, heat, cold, non-optimal nutrient or salt levels, non-optimal light levels) or of biotic stress (e. g., crowding, allelopathy, or wounding); by improved resistance to a pest or pathogen (e. g., insect, nematode, fungal, bacterial, or viral pest or pathogen) of the plant; by a modified primary metabolite (e. g., fatty acid, oil, amino acid, protein, sugar, or carbohydrate) composition; a modified secondary metabolite (e.
  • abiotic stress e. g., tolerance of water deficit or drought, heat, cold, non-optimal nutrient or salt levels, non-optimal light levels
  • biotic stress e. g., crowding, allelopathy, or wounding
  • a pest or pathogen e. g., insect, nema
  • alkaloids, terpenoids, polyketides, non-ribosomal peptides, and secondary metabolites of mixed biosynthetic origin composition
  • a modified trace element e. g., iron, zinc
  • carotenoid e. g., beta-carotene, lycopene, lutein, zeaxanthin, or other carotenoids and xanthophylls
  • vitamin e. g., tocopherols
  • improved yield e. g., improved yield under non-stress conditions or improved yield under biotic or abiotic stress
  • improved ability to use nitrogen or other nutrients modified agronomic characteristics (e.
  • modified growth or reproductive characteristics e. g., intentional dwarfing; intentional male sterility, useful, e. g., in improved hybridization procedures; improved vegetative growth rate; improved germination; improved male or female fertility
  • improved harvest, storage, or processing quality e. g., improved resistance to pests during storage, improved resistance to breakage, improved appeal to consumers
  • transgenic seed or seed produced by the transgenic plant, has modified primary metabolite (e. g., fatty acid, oil, amino acid, protein, sugar, or carbohydrate) composition, a modified secondary metabolite (e. g., alkaloids, terpenoids, polyketides, non-ribosomal peptides, and secondary metabolites of mixed biosynthetic origin) composition, a modified trace element (e. g., iron, zinc), carotenoid (e. g., beta-carotene, lycopene, lutein, zeaxanthin, or other carotenoids and xanthophylls), or vitamin (e.
  • modified primary metabolite e. g., fatty acid, oil, amino acid, protein, sugar, or carbohydrate
  • a modified secondary metabolite e. g., alkaloids, terpenoids, polyketides, non-ribosomal peptides, and secondary metabolites of mixed bio
  • tocopherols ) composition, an improved harvest, storage, or processing quality, or a combination of these.
  • amino acid e. g., lysine, methionine, tryptophan, or total protein
  • oil e. g., fatty acid composition or total oil
  • carbohydrate e. g., simple sugars or starches
  • trace element e. g., carotenoid, or vitamin content of seeds of crop plants (e. g., canola, cotton, safflower, soybean, sugarbeet, sunflower, wheat, maize, or rice), preferably in combination with improved seed harvest, storage, or processing quality, and thus provide improved seed for use in animal feeds or human foods.
  • an allergenic protein or glycoprotein e. g., peanut allergens including ara h 1, wheat allergens including gliadins and glutenins, soy allergens including P34 allergen, globulins, glycinins, and cong
  • This example illustrates a non-limiting example of a method of modifying the degree of silencing of a target gene, including transcribing in a eukaryotic cell a, thereby obtaining a modified degree of silencing of the target gene, relative to a modified suppression element reference degree of silencing obtained through the transcription in the eukaryotic cell of a reference suppression element that corresponds to the target gene. More particularly, this example describes a method including selection of a modified suppression element by mapping silencing efficacy.
  • Mapping the silencing efficacy of suppression elements for the target gene can be carried out, for example, by empirically determining the silencing efficacy of each of a plurality of fragments of a given reference suppression element that corresponds to the target gene.
  • One embodiment of the method includes “scanning” the reference suppression element, that is, determining the silencing efficacy of fragments of the reference suppression element.
  • the first fragments can be contiguous or non-contiguous, and can overlap. Generally, each of the first fragments includes from about 1% to about 98% of the reference suppression element; however, the reference suppression element may be divided into as many first fragments as is convenient or desirable.
  • One non-limiting example of scanning includes the steps of: (a) providing a reference suppression element corresponding to the target gene, wherein transcription of the reference suppression element in a eukaryotic cell results in a reference degree of silencing of the target gene; (b) providing a plurality of first fragments of the reference suppression element; and (c) empirically determining the degree of silencing of the target gene for each of the first fragments when transcribed in the eukaryotic cell; and (d) selecting at least one first fragment that provides a desired degree of silencing of the target gene for use in a modified suppression element.
  • Another non-limiting example of scanning includes the steps of: (a) providing a reference suppression element corresponding to the target gene, wherein transcription of the reference suppression element in a eukaryotic cell results in a reference degree of silencing of the target gene; (b) providing a plurality of first fragments of the reference suppression element; (c) empirically determining the degree of silencing of the target gene for each of the first fragments when transcribed in the eukaryotic cell; (d) selecting at least one first fragment that provides a desired degree of silencing of the target gene for use in a modified suppression element; (e) for the selected at least one first fragment, providing a plurality of second fragments each consisting of nucleotide segments of the first fragment; empirically determining the degree of silencing of the target gene for each of the second fragments when transcribed in the eukaryotic cell; and (f) selecting at least one second fragment that provides a desired degree of silencing of the target gene for use in a modified suppression element.
  • the fragments can be contiguous or non-contiguous, and can overlap.
  • the second fragments consist of from about one nucleotide shorter than the at least one first fragment to about 21 nucleotides in length. Fragments thus derived can be combined, e. g., as multiple copies of one or more fragments in chimeric combinations, or in combination with other suppression elements or expression elements.
  • the method of the invention is further illustrated by the following example, which describes mapping silencing efficacy of suppression elements for the target gene corn rootworm V-ATPase subunit A by analysis of fragments of a reference suppression element ( FIG. 1 ).
  • a bioassay for larval mortality served as a proxy measurement of target gene silencing efficacy.
  • the reference suppression element a ⁇ 600 nucleotide segment of Western corn rootworm (“WCR”, Diabrotica virgifera ) V-ATPase subunit A was found to induce a reference degree of silencing of ⁇ 79% mortality when fed as double-stranded RNA (0.02 ppm) to WCR larvae.
  • Another suppression element consisting of a 100 nucleotide subfragment of the ⁇ 150 nucleotide fragment that induced 75% mortality at 0.02 ppm ( FIG. 1 ), was selected for further efficacy mapping.
  • the 100 base pair fragment was amplified by PCR with the appropriate primers to produce an antisense template and a sense template.
  • the sense and antisense reactions were mixed, heated to 75 degrees Celsius for 5 minutes and allowed to cool to room temperature.
  • the resulting annealed 100 base pair double-stranded RNA product was purified with the MEGAscriptTM RNAi Kit (Ambion, Cat #1626) according to the manufacturer's instructions to produce a 100 base pair dsRNA product which was then tested with the same WCR larval bioassay.
  • the 100 bp suppression element was further mapped at a resolution of 26 bp fragments in a 5 bp register ( FIG. 1 ).
  • 26 bp segments designated scans 0 to 14
  • sense and antisense oligonucleotides were produced synthetically (Integrated DNA Technologies) as sense and antisense oligonucleotides.
  • Each pair of sense and antisense oligonucleotides was annealed, and a 3′ overhang was added by PCR with REDtaq polymerase.
  • the fifteen cloned 26 bp segments were verified for correct sequence and orientation, and used as PCR templates.
  • PCR reaction products were checked on agarose gels for correct size and quality, and amplified for dsRNA synthesis using MEGAscript RNAi Kit (Ambion, Cat #1626). Final dsRNA products were quantified by absorption at 260 nanometers, and visualized on a 1-3% agarose gel to ensure intactness of the product.
  • Double-stranded RNA corresponding to the fifteen 26 bp fragments (Scan 0 to Scan 14, see Table 1 and FIG. 1 ) was amplified in a larger neutral carrier (vector backbone sequence), and dsRNA was synthesized for a total assayed dsRNA length of 206 bp. All samples for insect bioassay were diluted to the final desired concentration in 10 millimolar Tris pH 6.8. Twenty microliters of each sample were applied to 200 microliters of insect diet and allowed to absorb into the diet before addition of a WCR neonate. Stunting and mortality of larvae was scored at day 12.
  • the dsRNAs synthesized from the 26 bp fragments resulted in a range of mortality from no significant difference from the untreated control to approximately 95% mortality (Scan 7 fragment).
  • a lower dose of 0.2 ppm was useful in identifying the most active segments, with observed mortality ranging from no significant difference from the untreated control (Scan 10 fragment) to 97% mortality (Scan 3 fragment) (Table 1 and FIG. 1 ).
  • Scan 14 (26 bp) was further mapped into its seven possible 21 bp fragments (designated scans 15-21) (Table 2 and FIG. 1 ). Attempts were made to clone all seven possible 21 mers, but cloning of scan 15 failed and the cloned scan 17 sequence was found to contain a point mutation. Nonetheless, the successfully cloned 21 mers were amplified to produce templates, and embedded in neutral (vector) carrier sequence to give a final dsRNA size of 184 bp. Samples were diluted, applied at 0.2 ppm, and assayed with the WCR larval diet bioassay as previously done. Most were found to possess significant activity (Table 2).
  • This example illustrates a non-limiting example of modifying the degree of silencing of a target gene, including transcribing in a eukaryotic cell a modified suppression element, thereby obtaining a modified degree of silencing of the target gene, relative to a reference degree of silencing obtained through the transcription in the eukaryotic cell of a reference suppression element that corresponds to the target gene. More particularly, this example describes a modified suppression element provided by truncation of a reference suppression element and a modified degree of silencing as evidenced by a modified phenotype in a seed containing the eukaryotic cell.
  • this example illustrates a method of providing a eukaryotic cell having a desired phenotype resulting from transcription in the eukaryotic cell of a modified suppression element.
  • the method includes the steps of: (a) providing a range of modified suppression elements, wherein each modified suppression element includes a fragment of a reference suppression element; (b) separately introducing each of the modified suppression elements into a eukaryotic cell, thereby producing a plurality of transgenic eukaryotic cells (c) transcribing in each of the transgenic eukaryotic cells the modified suppression element therein introduced, and observing the resulting phenotype resulting from the transcribing; and (d) selecting from the plurality of transgenic eukaryotic cells at least one eukaryotic cell having the desired phenotype.
  • the eukaryotic cell is a plant cell, specifically a transgenic crop plant cell
  • the target gene includes non-coding sequence
  • the modified suppression elements are a series of truncations of a reference suppression element
  • the desired phenotype is observed in a seed including the transgenic crop plant cell.
  • the target gene in this example is non-coding sequence, an intron of a soybean ( Glycine max ) fatty acid desaturase FAD2 or delta-12 desaturase gene, which encodes an enzyme that catalyzes the insertion of a double bond into a monounsaturated 18:1 fatty acid to form a polyunsaturated 18:2 fatty acid. Suppression of FAD2 results in an increase of 18:1 fatty acid content in the seed.
  • the degree of silencing of the target gene was modified by use of modified suppression elements.
  • modified suppression elements Examples of recombinant DNA constructs, including constructs containing suppression elements targetting FAD2 sequences, and detailed descriptions of their use, as well as of methods to make and use transgenic soybean seed, are provided in United States Patent Application Publication 2004/0107460, which is incorporated by reference in its entirety herein.
  • a reference suppression element including sequence that transcribed to double-stranded RNA corresponding to the FAD2 intron was introduced into soybean by Agrobacterium -mediated stable transformation, resulting in increased 18:1 fatty acid content.
  • each modified suppression element was derived by truncation of the reference suppression element to correspond respectively to a deletion of ⁇ 160, ⁇ 240, or ⁇ 320 nucleotides from the 5′ end of the target gene (FAD2 intron).
  • Each modified suppression element was introduced into soybean cells by Agrobacterium -mediated stable transformation, and stably transformed soybean plants generated.
  • FIG. 2 depicts the results of transcribing the modified suppression element in soybean, where, on average, the degree of FAD2 silencing (observed as increased 18:1 fatty acid levels) was modulated or decreased in comparison to that obtained with the reference suppression element.
  • Fatty acid content of individual seeds (six seeds per transformation event, with each event indicated on the x-axis of FIG.
  • each modified suppression element was derived by truncation of the reference suppression element to correspond respectively to a deletion of ⁇ 160, ⁇ 240, or ⁇ 320 nucleotides from the 5′ end of the target gene (FAD2 intron) or to a deletion of ⁇ 200, ⁇ 240, ⁇ 260, ⁇ 300, ⁇ 320, ⁇ 360, ⁇ 380, ⁇ 400 nucleotides from the 3′ end of the target gene (FAD2 intron).
  • a suppression element corresponding to complete deletion (421 nucleotides) of the target gene (FAD2 intron) served as a control.

Landscapes

  • Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • General Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Plant Pathology (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Cell Biology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Virology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Edible Oils And Fats (AREA)
US11/674,207 2006-02-13 2007-02-13 Modified Gene Silencing Abandoned US20070192903A1 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
US11/674,207 US20070192903A1 (en) 2006-02-13 2007-02-13 Modified Gene Silencing
US12/749,553 US20100240128A1 (en) 2006-02-13 2010-03-30 Modified Gene Silencing
US14/322,393 US9765351B2 (en) 2006-02-13 2014-07-02 Modified gene silencing
US15/702,384 US20180002712A1 (en) 2006-02-13 2017-09-12 Modified Gene Silencing
US16/701,782 US11708577B2 (en) 2006-02-13 2019-12-03 Modified gene silencing

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US77261406P 2006-02-13 2006-02-13
US11/674,207 US20070192903A1 (en) 2006-02-13 2007-02-13 Modified Gene Silencing

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US12/749,553 Division US20100240128A1 (en) 2006-02-13 2010-03-30 Modified Gene Silencing

Publications (1)

Publication Number Publication Date
US20070192903A1 true US20070192903A1 (en) 2007-08-16

Family

ID=40631448

Family Applications (5)

Application Number Title Priority Date Filing Date
US11/674,207 Abandoned US20070192903A1 (en) 2006-02-13 2007-02-13 Modified Gene Silencing
US12/749,553 Abandoned US20100240128A1 (en) 2006-02-13 2010-03-30 Modified Gene Silencing
US14/322,393 Active 2027-05-30 US9765351B2 (en) 2006-02-13 2014-07-02 Modified gene silencing
US15/702,384 Abandoned US20180002712A1 (en) 2006-02-13 2017-09-12 Modified Gene Silencing
US16/701,782 Active 2027-08-17 US11708577B2 (en) 2006-02-13 2019-12-03 Modified gene silencing

Family Applications After (4)

Application Number Title Priority Date Filing Date
US12/749,553 Abandoned US20100240128A1 (en) 2006-02-13 2010-03-30 Modified Gene Silencing
US14/322,393 Active 2027-05-30 US9765351B2 (en) 2006-02-13 2014-07-02 Modified gene silencing
US15/702,384 Abandoned US20180002712A1 (en) 2006-02-13 2017-09-12 Modified Gene Silencing
US16/701,782 Active 2027-08-17 US11708577B2 (en) 2006-02-13 2019-12-03 Modified gene silencing

Country Status (3)

Country Link
US (5) US20070192903A1 (zh)
CN (1) CN101421406B (zh)
AR (1) AR110665A2 (zh)

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090271893A1 (en) * 1999-08-26 2009-10-29 Fillatti Joanne J Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids
US20110003290A1 (en) * 2007-10-22 2011-01-06 Nittaya Gale Oligonucleotides and Uses Thereof
WO2011060151A2 (en) * 2009-11-11 2011-05-19 Kansas State University Research Foundation Compositions and methods for controlling parasitic nematodes
US7968525B1 (en) 2007-12-03 2011-06-28 University Of Florida Research Foundation, Inc. Use of RNA interference to validate new termiticide target sites and a method of termite control
US9222100B2 (en) 2010-08-24 2015-12-29 Monsanto Technology Llc Methods and DNA constructs for autoregulating transgene silencing
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN102164476A (zh) 2008-09-29 2011-08-24 孟山都技术公司 大豆转基因事件mon87705及其检测方法
EP2501804B1 (en) * 2009-11-20 2016-03-30 Bayer CropScience NV Brassica plants comprising mutant fad3 alleles
CA2782423C (en) * 2009-12-18 2019-06-18 Cargill Incorporated Brassica plants yielding oils with a low total saturated fatty acid content
CN101736030B (zh) * 2010-01-08 2012-05-23 河南科技大学 一种杨树乙酰-乙酰载体蛋白硫脂酶基因RNAi载体及其应用
US9695434B2 (en) 2010-05-25 2017-07-04 Cargill, Incorporated Brassica plants yielding oils with a low alpha linolenic acid content
RU2012156277A (ru) 2010-05-25 2014-06-27 Карджилл, Инкорпорейтед Растения brassica, дающие масла с низким содержанием альфа-линоленовой кислоты
EP2588617B1 (en) * 2010-07-01 2015-12-30 E. I. du Pont de Nemours and Company Plant seeds with altered storage compound levels, related constructs and methods involving genes encoding pae and pae-like polypeptides
US10196662B2 (en) 2012-08-10 2019-02-05 Mello Biotechnology, Inc. Composition for producing microRNA precursors as drugs for enhancing wound healing and production method of the microRNA precursors
CN103525931A (zh) * 2013-10-16 2014-01-22 山东省花生研究所 一种花生高油酸性状基因选择方法
BR112017000414A2 (pt) * 2014-07-10 2017-11-07 Terravia Holdings Inc genes cetoacil-acp sintase e utilizações dos mesmos
CN108456679B (zh) * 2018-02-03 2021-07-30 吉林省农业科学院 高油酸转基因大豆事件e2d8037-3外源插入片段侧翼序列及其应用
CN110760608B (zh) * 2019-12-02 2020-07-14 浙江省农业科学院 一种油菜BnFAD2基因高油酸等位突变及其SNP标记引物的开发和应用
JP2023519087A (ja) * 2020-01-31 2023-05-10 カリックス インコーポレイテッド ダイズにおける飽和脂肪の増加

Family Cites Families (116)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208149A (en) 1983-10-20 1993-05-04 The Research Foundation Of State University Of New York Nucleic acid constructs containing stable stem and loop structures
US5272065A (en) 1983-10-20 1993-12-21 Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US5190931A (en) 1983-10-20 1993-03-02 The Research Foundation Of State University Of New York Regulation of gene expression by employing translational inhibition of MRNA utilizing interfering complementary MRNA
US4557734A (en) 1984-08-08 1985-12-10 The United States Of America As Represented By The Secretary Of Agriculture Microemulsions from vegetable oil and lower alcohol with octanol surfactant as alternative fuel for diesel engines
US5453566A (en) 1986-03-28 1995-09-26 Calgene, Inc. Antisense regulation of gene expression in plant/cells
US5107065A (en) 1986-03-28 1992-04-21 Calgene, Inc. Anti-sense regulation of gene expression in plant cells
US5188958A (en) 1986-05-29 1993-02-23 Calgene, Inc. Transformation and foreign gene expression in brassica species
US5004863B2 (en) 1986-12-03 2000-10-17 Agracetus Genetic engineering of cotton plants and lines
US5015580A (en) 1987-07-29 1991-05-14 Agracetus Particle-mediated transformation of soybean plants and lines
US5534425A (en) 1988-02-03 1996-07-09 Iowa State University Research Foundation, Inc. Soybeans having low linolenic acid content and method of production
US5416011A (en) 1988-07-22 1995-05-16 Monsanto Company Method for soybean transformation and regeneration
US5231020A (en) 1989-03-30 1993-07-27 Dna Plant Technology Corporation Genetic engineering of novel plant phenotypes
US5550318A (en) 1990-04-17 1996-08-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US7705215B1 (en) 1990-04-17 2010-04-27 Dekalb Genetics Corporation Methods and compositions for the production of stably transformed, fertile monocot plants and cells thereof
US5585535A (en) 1990-01-05 1996-12-17 Iowa State University Research Foundation, Inc. Soybeans and soybean products having low palmitic acid content
HU220773B1 (hu) 1990-01-22 2002-05-28 Dekalb Genetics Corporation Eljárás termő transzgenikus kukoricanövények előállítására
US5484956A (en) 1990-01-22 1996-01-16 Dekalb Genetics Corporation Fertile transgenic Zea mays plant comprising heterologous DNA encoding Bacillus thuringiensis endotoxin
US7037692B1 (en) 1990-03-16 2006-05-02 Calgene, Inc. Plant desaturases compositions and uses
US5475099A (en) 1990-08-15 1995-12-12 Calgene Inc. Plant fatty acid synthases
US6403865B1 (en) 1990-08-24 2002-06-11 Syngenta Investment Corp. Method of producing transgenic maize using direct transformation of commercially important genotypes
US5633435A (en) 1990-08-31 1997-05-27 Monsanto Company Glyphosate-tolerant 5-enolpyruvylshikimate-3-phosphate synthases
US6022577A (en) 1990-12-07 2000-02-08 Nabisco Technology Company High stearic acid soybean oil blends
WO1992020809A1 (en) 1991-05-15 1992-11-26 Agracetus, Inc. Method of creating a transformed rice plant
US5763245A (en) 1991-09-23 1998-06-09 Monsanto Company Method of controlling insects
US5518908A (en) 1991-09-23 1996-05-21 Monsanto Company Method of controlling insects
CA2123495A1 (en) 1991-11-15 1993-05-27 Anthony J. Kinney B-ketoacyl-acp synthetase ii genes from plants
US5593874A (en) 1992-03-19 1997-01-14 Monsanto Company Enhanced expression in plants
ATE398679T1 (de) 1992-07-07 2008-07-15 Japan Tobacco Inc Verfahren zur transformation einer monokotyledon pflanze
WO1994010189A1 (en) 1992-11-02 1994-05-11 Calgene, Inc. Plant fatty acid synthases
CA2149223C (en) 1992-11-17 2007-04-24 Jonathan Edward Lightner Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants
US6372965B1 (en) * 1992-11-17 2002-04-16 E.I. Du Pont De Nemours And Company Genes for microsomal delta-12 fatty acid desaturases and hydroxylases from plants
US6872872B1 (en) 1992-11-17 2005-03-29 E. I. Du Pont De Nemours And Company Genes for microsomal delta-12 fatty acid desaturases and related enzymes from plants
US6118047A (en) 1993-08-25 2000-09-12 Dekalb Genetic Corporation Anthranilate synthase gene and method of use thereof for conferring tryptophan overproduction
CA2176137A1 (en) 1993-11-10 1995-05-18 Alois Toni Voelker Plant acyl acp thioesterase sequences
US5516980A (en) 1994-01-10 1996-05-14 Iowa State University Research Foundation, Inc. Soybean variety XB37ZA
JPH10505237A (ja) * 1994-08-31 1998-05-26 イー・アイ・デユポン・ドウ・ヌムール・アンド・カンパニー カノラ及びダイズのパルミトイル−ａｃｐチオエステラーゼ遺伝子のヌクレオチド配列、並びにダイズ及びカノラ植物の油の脂肪酸量の調節におけるこれらの使用
US5631152A (en) 1994-10-26 1997-05-20 Monsanto Company Rapid and efficient regeneration of transgenic plants
US5454842A (en) 1994-12-02 1995-10-03 Exxon Research & Engineering Co. Cetane improver compositions comprising nitrated fatty acid derivatives
US6150512A (en) 1995-05-15 2000-11-21 Yuan; Ling Engineering plant thioesterases and disclosure of plant thioesterases having novel substrate specificity
US5955329A (en) 1995-05-15 1999-09-21 Calgene, Inc. Engineering plant thioesterases for altered substrate specificity
EP0858496B1 (en) 1995-06-06 2005-03-09 Agro Management Group, Inc. Vegetable based biodegradable liquid lubricants
ZA973565B (en) 1996-04-26 1998-10-26 Du Pont Soybean oil having high oxidative stability
US5850026A (en) 1996-07-03 1998-12-15 Cargill, Incorporated Canola oil having increased oleic acid and decreased linolenic acid content
DE19631919C2 (de) 1996-08-07 1998-07-16 Deutsches Krebsforsch Anti-Sinn-RNA mit Sekundärstruktur
US5750848A (en) 1996-08-13 1998-05-12 Monsanto Company DNA sequence useful for the production of polyhydroxyalkanoates
ATE282705T1 (de) 1996-09-03 2004-12-15 Bayer Bioscience Nv Verbessertes barstar-gen
US5850030A (en) 1996-12-23 1998-12-15 Iowa State University Research Foundation, Inc. Reduced linolenic acid production in soybeans
EP0969714A4 (en) 1997-01-10 2004-10-06 Univ California RESISTANCE GENE NUCLEIC ACIDS FOR PROVIDING DISEASE RESISTANCE PLANTS
US5981840A (en) 1997-01-24 1999-11-09 Pioneer Hi-Bred International, Inc. Methods for agrobacterium-mediated transformation
DE19702989A1 (de) 1997-01-28 1998-07-30 Clariant Gmbh Umweltfreundlicher Dieseltreibstoff
AR013633A1 (es) 1997-04-11 2001-01-10 Calgene Llc METODO PARA LA ALTERACIoN DE LA COMPOSICIoN DE ÁCIDOS GRASOS DE CADENA MEDIA EN SEMILLAS VEGETALES QUE EXPRESAN UNA TIOESTERASA QUE PREFIERE CADENA MEDIA VEGETAL HETERoLOGA.
WO1998050569A2 (en) 1997-05-05 1998-11-12 Dow Agrosciences Llc Nucleotide sequences of maize oleoyl-acp thioesterase and palmitoyl-acp thioesterase genes and their use in the modification of fatty acid content of oil
GB9710475D0 (en) 1997-05-21 1997-07-16 Zeneca Ltd Gene silencing
US6933378B2 (en) 1997-05-30 2005-08-23 Joseph Atabekov Methods for coexpression of more than one gene in eukaryotic cells
WO1998056239A1 (en) 1997-06-12 1998-12-17 Cargill, Incorporated Fatty acid desaturases and mutant sequences thereof
GB9720148D0 (en) 1997-09-22 1997-11-26 Innes John Centre Innov Ltd Gene silencing materials and methods
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
US5891203A (en) 1998-01-20 1999-04-06 Ethyl Corporation Fuel lubricity from blends of a diethanolamine derivative and biodiesel
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
BRPI9908967B1 (pt) 1998-03-20 2017-05-30 Benitec Australia Ltd processos para reprimir, retardar ou de outro modo reduzir a expressão de um gene alvo em uma célula de planta
JP5015373B2 (ja) 1998-04-08 2012-08-29 コモンウェルス サイエンティフィック アンド インダストリアル リサーチ オーガニゼイション 改良表現型を得るための方法及び手段
US6426448B1 (en) 1998-05-11 2002-07-30 E. I. Du Pont De Nemours And Company Gene combinations that alter the quality and functionality of soybean oil
US6307123B1 (en) 1998-05-18 2001-10-23 Dekalb Genetics Corporation Methods and compositions for transgene identification
EP0959133A1 (en) 1998-05-22 1999-11-24 Centrum Voor Plantenveredelings- En Reproduktieonderzoek (Cpro-Dlo) A process for inhibiting expression of genes
AR020078A1 (es) 1998-05-26 2002-04-10 Syngenta Participations Ag Metodo para alterar la expresion de un gen objetivo en una celula de planta
JP2002517201A (ja) 1998-06-05 2002-06-18 カルジーン エルエルシー アシルＣｏＡ：コレステロールアシルトランスフェラーゼ関連核酸配列
US7008664B1 (en) 1998-06-11 2006-03-07 E. I. Du Pont De Nemours And Company Method for improving the carcass quality of an animal
EP1098962B1 (en) 1998-07-02 2009-09-09 Calgene LLC Diacylglycerol acyl transferase proteins
US6281375B1 (en) 1998-08-03 2001-08-28 Cargill, Incorporated Biodegradable high oxidative stability oils
US6365802B2 (en) 1998-08-14 2002-04-02 Calgene Llc Methods for increasing stearate content in soybean oil
US6717034B2 (en) 2001-03-30 2004-04-06 Mendel Biotechnology, Inc. Method for modifying plant biomass
WO2000018880A2 (en) 1998-09-30 2000-04-06 The Regents Of The University Of California Inhibition of farnesyltransferase activity in plants
AU2848800A (en) 1999-01-14 2000-08-01 Monsanto Technology Llc Soybean transformation method
US6733965B2 (en) 1999-01-15 2004-05-11 International Paper Company Microsatellite DNA markers and uses thereof
WO2000044914A1 (en) 1999-01-28 2000-08-03 Medical College Of Georgia Research Institute, Inc. Composition and method for in vivo and in vitro attenuation of gene expression using double stranded rna
DE19956568A1 (de) 1999-01-30 2000-08-17 Roland Kreutzer Verfahren und Medikament zur Hemmung der Expression eines vorgegebenen Gens
PL351385A1 (en) 1999-05-10 2003-04-07 Syngenta Participations Ag Regulation of viral gene expression
US6429357B1 (en) 1999-05-14 2002-08-06 Dekalb Genetics Corp. Rice actin 2 promoter and intron and methods for use thereof
US6194636B1 (en) 1999-05-14 2001-02-27 Dekalb Genetics Corp. Maize RS324 promoter and methods for use thereof
US6207879B1 (en) 1999-05-14 2001-03-27 Dekalb Genetics Corporation Maize RS81 promoter and methods for use thereof
US6232526B1 (en) 1999-05-14 2001-05-15 Dekalb Genetics Corp. Maize A3 promoter and methods for use thereof
WO2001011061A2 (en) 1999-08-04 2001-02-15 The University Of British Columbia Regulation of embryonic transcription in plants
ATE383433T1 (de) 1999-08-26 2008-01-15 Calgene Llc Pflanzen mit veränderten mehrfachungesättigten fettsäuren
US7067722B2 (en) * 1999-08-26 2006-06-27 Monsanto Technology Llc Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
CA2390049C (en) 1999-11-12 2012-01-24 University Of South Carolina Control of post-transcriptional gene silencing in plants
CA2391446A1 (en) 1999-11-17 2001-05-25 Mendel Biotechnology, Inc. Plant biochemistry-related genes
CA2396359C (en) 2000-01-07 2019-09-17 Monsanto Technology Llc Nucleic acid molecules and other molecules associated with soybean cyst nematode resistance
US20020133852A1 (en) 2000-01-07 2002-09-19 Hauge Brian M. Soybean SSRs and methods of genotyping
US6369296B1 (en) 2000-02-01 2002-04-09 Plant Bioscience Limited Recombinant plant viral vectors
PL358230A1 (en) 2000-03-17 2004-08-09 Benitec Australia Ltd Genetic silencing
ATE476514T1 (de) 2000-04-18 2010-08-15 Commw Scient Ind Res Org Verfahren zur modifizierung des baumwollölgehaltes
JP3829595B2 (ja) 2000-07-06 2006-10-04 不二製油株式会社 耐寒性油脂組成物及びその製造法
US20020058340A1 (en) 2000-08-02 2002-05-16 Clemente Thomas E. Down-regulation of single genes and simultaneous down-regulation of multiple genes by nuclear localization of RNA transcripts
EP2410060A1 (en) 2000-08-22 2012-01-25 Mendel Biotechnology, Inc. Genes for modifying plant traits IV
US7151204B2 (en) 2001-01-09 2006-12-19 Monsanto Technology Llc Maize chloroplast aldolase promoter compositions and methods for use thereof
US6800748B2 (en) 2001-01-25 2004-10-05 Large Scale Biology Corporation Cytoplasmic inhibition of gene expression and expression of a foreign protein in a monocot plant by a plant viral vector
EP1354035B1 (en) 2001-01-26 2016-08-24 Commonwealth Scientific and Industrial Research Organisation Methods and means for producing efficient silencing construct using recombinational cloning
WO2002062129A2 (en) 2001-02-06 2002-08-15 Dow Agrosciences Llc High oil maize plants, and methods for obtaining same
WO2002081711A1 (en) 2001-04-06 2002-10-17 Cropdesign N.V. The use of double and opposite recombination sites for the single step cloning of two dna segments
WO2002088301A2 (en) 2001-05-02 2002-11-07 Gavish Galilee Bio Applications Ltd. Increased methionine in transgenic plants expressing mutant cystathionine gamma-synthase
EP1458876A2 (en) 2001-12-18 2004-09-22 Bayer BioScience N.V. Improved methods and means for delivering inhibitory rna to plants and applications thereof
US7566813B2 (en) 2002-03-21 2009-07-28 Monsanto Technology, L.L.C. Nucleic acid constructs and methods for producing altered seed oil compositions
CN100510084C (zh) 2002-03-21 2009-07-08 孟山都技术有限公司 核酸构建体及其生产改良的种子油组合物的方法
US20040107460A1 (en) 2002-03-21 2004-06-03 Fillatti Joanne J. Nucleic acid constructs and methods for producing altered seed oil compositions
US7166771B2 (en) 2002-06-21 2007-01-23 Monsanto Technology Llc Coordinated decrease and increase of gene expression of more than one gene using transgenic constructs
JP2005530506A (ja) 2002-06-21 2005-10-13 モンサント テクノロジー エルエルシー 改変された脂肪酸組成を持つ植物の生成のためのチオエステラーゼ関連核酸配列およびその使用方法
AR039717A1 (es) * 2002-06-21 2005-03-09 Monsanto Technology Llc Construcciones de arn de intrones cadena doble y usos de las mismas
AUPS325302A0 (en) 2002-06-27 2002-07-18 Satellite Telemetry (Aust) Pty. Limited Straddle carrier position guidance system
AU2003247951A1 (en) 2002-07-10 2004-01-23 Kansas State University Research Foundation Compositions and methods for controlling parasitic nematodes
WO2004046336A2 (en) * 2002-11-18 2004-06-03 Monsanto Technology, Llc Production of increased oil and protein in plants by the disruption of the phenylpropanoid pathway
WO2005007829A2 (en) 2003-07-14 2005-01-27 Monsanto Technology, Llc Materials and methods for the modulation of cyclin-dependent kinase inhibitor-like polypeptides in maize
EP1766032B1 (en) 2004-02-13 2012-10-10 Monsanto Technology, LLC In vivo assembly of transcription units
ES2547381T3 (es) 2004-04-09 2015-10-05 Monsanto Technology, Llc Composiciones y procedimientos de control de infestaciones de insectos en plantas
US20060200878A1 (en) 2004-12-21 2006-09-07 Linda Lutfiyya Recombinant DNA constructs and methods for controlling gene expression
CA2637363C (en) 2006-02-13 2016-04-05 Monsanto Technology Llc Selecting and stabilizing dsrna constructs
CN103002727B (zh) 2009-07-08 2016-04-27 密苏里大学管委会 利用传统大豆育种技术培育高油酸大豆的方法

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20090271893A1 (en) * 1999-08-26 2009-10-29 Fillatti Joanne J Nucleic Acid Sequences and Methods of Use for the Production of Plants with Modified Polyunsaturated Fatty Acids
US8097778B2 (en) 1999-08-26 2012-01-17 Monsanto Company Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids
US20110003290A1 (en) * 2007-10-22 2011-01-06 Nittaya Gale Oligonucleotides and Uses Thereof
US9404148B2 (en) * 2007-10-22 2016-08-02 Lgc Limited Oligonucleotides and uses thereof
US7968525B1 (en) 2007-12-03 2011-06-28 University Of Florida Research Foundation, Inc. Use of RNA interference to validate new termiticide target sites and a method of termite control
WO2011060151A2 (en) * 2009-11-11 2011-05-19 Kansas State University Research Foundation Compositions and methods for controlling parasitic nematodes
WO2011060151A3 (en) * 2009-11-11 2011-09-29 Kansas State University Research Foundation Compositions and methods for controlling parasitic nematodes
US9297022B2 (en) 2009-11-11 2016-03-29 Kansas State University Research Foundation Compositions and methods for controlling parasitic nematodes
US9222100B2 (en) 2010-08-24 2015-12-29 Monsanto Technology Llc Methods and DNA constructs for autoregulating transgene silencing
US9850512B2 (en) 2013-03-15 2017-12-26 The Research Foundation For The State University Of New York Hydrolysis of cellulosic fines in primary clarified sludge of paper mills and the addition of a surfactant to increase the yield
US9951363B2 (en) 2014-03-14 2018-04-24 The Research Foundation for the State University of New York College of Environmental Science and Forestry Enzymatic hydrolysis of old corrugated cardboard (OCC) fines from recycled linerboard mill waste rejects

Also Published As

Publication number Publication date
AR110665A2 (es) 2019-04-17
CN101421406B (zh) 2016-08-31
US20180002712A1 (en) 2018-01-04
US20140315312A1 (en) 2014-10-23
US20100240128A1 (en) 2010-09-23
US11708577B2 (en) 2023-07-25
US9765351B2 (en) 2017-09-19
US20200109410A1 (en) 2020-04-09
CN101421406A (zh) 2009-04-29

Similar Documents

Publication Publication Date Title
US11708577B2 (en) Modified gene silencing
US8404927B2 (en) Double-stranded RNA stabilized in planta
US20180002713A1 (en) Recombinant DNA Constructs and Methods for Controlling Gene Expression
US9309512B2 (en) Phased small RNAs
EP1824967B1 (en) Recombinant dna constructs and methods for controlling gene expression
CN101802215A (zh) 植物微rna及其使用方法
BRPI0617224B1 (pt) Constructos de dna recombinantes
AU2013203734A1 (en) Phased small RNAs

Legal Events

Date Code Title Description
STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION